Mansouramycin A

Mansouramycin A

SCHEMBL29884737

CNC1=CC(=O)c2c(cnc(C)c2C)C1=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30317599 0.72 MAPT (0.37) —
SCHEMBL16433204 0.72 AXL (0.38) —
SCHEMBL30317483 0.66 TP53 (0.40) —
SCHEMBL30754597 0.63 PTGS2 (0.31) —
SCHEMBL4540326 0.62 MAPT (0.61) —
SCHEMBL29633340 0.62 MAPT (0.61) —
SCHEMBL30594079 0.62 MAPT (0.63) —
SCHEMBL11658096 0.60 DNM1 (0.37) —
Mansouramycin B SCHEMBL29886187 0.58 MAPT (0.36) —
SCHEMBL359515 0.58 MAPT (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11421223-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2022-08-23 — — US disclosed
Send feedback